Reporting Manager
Point72 Asset Management, L.P.
Symbol
RLAY
Shares outstanding
170,073,982 shares
Disclosed Ownership
9,694,217 shares
Ownership
5.7%
Form type
SCHEDULE 13G
Filing time
20 Mar 2025, 18:13:29 UTC
Date of event
14 Mar 2025
Next filing
14 Aug 2025

Sponsored

Quoteable Key Fact

"Point72 Asset Management, L.P. disclosed 5.7% ownership in Relay Therapeutics, Inc. Common Stock, par value $0.001 per share (RLAY) on 14 Mar 2025."

Quick Takeaways

  • Point72 Asset Management, L.P. filed SCHEDULE 13G for Relay Therapeutics, Inc. Common Stock, par value $0.001 per share (RLAY).
  • Disclosed ownership: 5.7%.
  • Date of event: 14 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 20 Mar 2025, 18:13.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 5.7% 9,694,217 0 9,694,217 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 5.7% 9,694,217 0 9,694,217 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 5.7% 9,694,217 0 9,694,217 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person